Institution Directory

Clinical trials at NYU Langone Health

Sites in New York, NY

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:43 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1147

Shown on this page

Current sort

Live official records

Conditions: IBS - Irritable Bowel Syndrome
Interventions: Psilocybin 25 mg, Psychotherapy Treatment Session, Niacin 100 mg; Drug · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Prosthetic-joint Infection
Interventions: Culturelle Digestive Daily Probiotic Capsule; Dietary Supplement
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 90 Years
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Familial Dysautonomia
Interventions: Dexmedetomidine Sublingual; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Total Knee Arthroplasty
Interventions: 3D-Printed Mechanical Balancer; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Deafness
Interventions: Single-Electrode Pulse Train, Modulation Detection Threshold (MDT) and Gap Detection Tasks, Sound coding strategy., Electric-only spectral resolution; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 6 Years to 80 Years
Enrollment: 190 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Hip Arthropathy
Interventions: Modified MRI; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 99 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Weight Change Trajectory, Weight Change, Body
Interventions: Revita Duodenal Mucosal Resurfacing (DMR), Sham; Device
Lead sponsor: Fractyl Health Inc.; Industry
Eligibility: 21 Years to 70 Years
Enrollment: 315 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 32
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Newport Beach, California + 24 more

Conditions: Geriatric Hip Fracture
Interventions: XR™ Recovery Supplement, XR Carbohydrate Loading Supplement; Dietary Supplement
Lead sponsor: NYU Langone Health; Other
Eligibility: 65 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Genetic Testing
Interventions: Natera® Empower™ hereditary cancer panel test, Specialist Referral; Genetic · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 25 Years to 39 Years · Female only
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Hearing Loss
Interventions: Cochlear implant, Dexamethasone; Device · Drug
Lead sponsor: Cochlear; Industry
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 11
States / cities: Los Angeles, California • Englewood, Colorado • Iowa City, Iowa + 6 more

Conditions: Sturge-Weber Syndrome
Interventions: Not listed
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 1 Month and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2027
U.S. locations: 7
States / cities: Baltimore, Maryland • Detroit, Michigan • New York, New York + 4 more

Conditions: Alzheimer's Disease Related Dementia, Alzheimer Disease
Interventions: Emergency Care Redesign (ECR), Nurse-led Telephonic Care (NLTC), Community Paramedic-led Transitions Intervention (CPTI); Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 66 Years and older
Enrollment: 19,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: New York, New York

About this NYU Langone Health institution page

What this page lists: ClinicalTrials.gov records that list NYU Langone Health in New York, NY as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at NYU Langone Health

Filter and sort this campus

Live official records

Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)

The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee

Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia

Utilization of a 3D Printed Mechanical Balancer During Total Knee Arthroplasty (TKA)

Novel Coding Strategies for Children With Cochlear Implants

Optimized MRI of Patients With Hip Arthroplasty

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Nutritional Supplementation in Geriatric Hip Fractures

Universal Genetic Testing for Cancer Risk Reduction

Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array

Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome

ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care

About this NYU Langone Health institution page